NCT04732052

Brief Summary

Aggressive behaviours are highly prevalent among people with developmental disabilities, both in community and inpatient or residential settings, with adverse consequences for the individuals involved and others. Some predictive factors, particularly impulsivity, are dynamic with neurobiological underpinnings, and as such amenable to change or neuromodulation using non-invasive brain stimulation techniques. With this in mind, we designed an experimental protocol to determine the efficacy of transcranial Direct Current Stimulation (tDCS) as a non-invasive brain stimulation technique to reduce impulsivity and aggression associated with developmental disability.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
32mo left

Started Sep 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress58%
Sep 2022Dec 2028

First Submitted

Initial submission to the registry

November 27, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 1, 2021

Completed
1.6 years until next milestone

Study Start

First participant enrolled

September 1, 2022

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2025

Completed
3.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Expected
Last Updated

March 25, 2025

Status Verified

March 1, 2025

Enrollment Period

3.1 years

First QC Date

November 27, 2020

Last Update Submit

March 21, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Aggression

    To determine the effect of tDCS treatment on aggressive symptoms measured by The Modified Overt Aggression Scale (MOAS); Total weighted scores range from 0-40, with a higher score indicating more aggressive behavior.

    change from baseline one week and one month after the third tDCS session

Secondary Outcomes (5)

  • Maladaptive behaviors

    change from baseline one week and one month after the third tDCS session

  • Intervention side effects

    Up to 72hrs after the first, second, and third active or sham tDCS treatments.

  • Trait Impulsivity

    Baseline

  • Impulsivity

    change from baseline and the same day after the third tDCS sessions

  • Treatment Acceptability

    Up to 72hrs after the third active or sham tDCS treatments.

Study Arms (2)

Active tDCS

ACTIVE COMPARATOR

Transcranial Direct Current Stimulation: Soterix tDCS kit will be used to deliver the stimulation using two sponge electrodes soaked in a saline solution. The stimulation montage will comprise of left anodal Dorsal Lateral Prefrontal cortex (DLPFC) stimulation. The anodal electrode will be placed over the area corresponding to the left DLPFC (F5 of the EEG10-20 international system) and the reference (cathodal) electrode over the right supraorbital ridge. The active stimulation condition will use a constant current of 2mA, delivered via gradual increase and decrease over 10 seconds at the onset and offset of stimulation (current ramps), respectively. The duration a single tDCS session will be 20 minutes.

Device: Transcranial Direct Current Stimulation

Sham tDCS

SHAM COMPARATOR

Sham Transcranial Direct Current Stimulation: Soterix tDCS kit will be used to deliver the sham stimulation using two sponge electrodes soaked in a saline solution. The sham stimulation montage will comprise of left anodal Dorsal Lateral Prefrontal cortex (DLPFC) stimulation for 10s only. The anodal electrode will be placed over the area corresponding to the left DLPFC (F5 of the EEG10-20 international system) and the reference (cathodal) electrode over the right supraorbital ridge. The sham tDCS is identical to the active tDCS except that the current will be delivered only in the first 10 seconds, after which the stimulation will cease but with the electrodes still in place throughout the session. The duration of each sham tDCS session will be 20 minutes.

Device: Transcranial Direct Current Stimulation

Interventions

non-invasive brain stimulator

Active tDCSSham tDCS

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18-64 years
  • Diagnosis of a developmental disability
  • History of one or more incidents of aggression in the last month
  • Consent to participate in the trial by the individual or their Substitute Decision Maker

You may not qualify if:

  • History of epilepsy or seizures
  • History of acquired brain injury
  • Having metal in the brain/skull, e.g. splinters, fragments or clips
  • Having a cochlear implant
  • Having an implanted neuro-stimulator (e.g. direct brain stimulation, epidural/subdural stimulation, vagal nerve stimulation)
  • History of brain surgery of procedure
  • History of severe adverse reaction to tDCS
  • Having a cardiac pacemaker or intracardiac lines
  • Current alcohol or drug misuse
  • Having a sensitive scalp

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Providence Care Hospital

Kingston, Ontario, K7L 4X3, Canada

RECRUITING

MeSH Terms

Conditions

Aggression

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Aberrant Motor Behavior in DementiaBehavioral SymptomsBehaviorSocial Behavior

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Muhammad Ayub, MD

    Queen's University

    STUDY CHAIR

Central Study Contacts

Najat Khalifa, MD

CONTACT

Andrew Bickle, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

November 27, 2020

First Posted

February 1, 2021

Study Start

September 1, 2022

Primary Completion

September 30, 2025

Study Completion (Estimated)

December 31, 2028

Last Updated

March 25, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will share

All collected IPD including all IPD that underlie results in publication.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
All IPD will be available at study end (in two years) and be available for five years following study end date.
Access Criteria
Designated study personnel only

Locations